Abdelsatir , A. A.,Husain , N. E.,Hassan , A. T.,Elmadhoun , W. M.,Almobarak , A. O.,Ahmed , M. H., 2015.Potential Benefit of Metformin as Treatment for Colon Cancer: the Evidence so Far,Asian Pac. J. Cancer Prev 16 8053 -8058
Al-Wahab , Z.,Mert , I.,Tebbe , C.,Chhina , J.,Hijaz , M.,Morris,Ali-Fehmi , R.,Giri , S.,Munkarah , A. R.,Rattan , R., 2015.Metformin prevents aggressive ovarian cancer growth driven by highenergy diet: similarity with calorie restriction,Oncotarget. 6 10908 -10923
Argun , M.,Uzum , K.,Sonmez , M. F.,Ozyurt , A.,Karabulut , D.,Soyersarica , Z.,Cilenk , K. T.,Unalmis , S.,Pamukcu , O.,Baykan , A.,Narin , F.,Elmali , F.,Narin , N., 2015.Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats,Anatol. J. Cardiol. 16 234 -241
Balogh , Z.,Matyus , J., 2012.Proposal for the modification of metformin use in patients with chronic kidney disease,Orv. Hetil. 153 1527 -1535
Bergheim , I.,Luyendyk , J. P.,Steele , C.,Russell , G. K.,Guo , L.,Roth , R. A.,Arteel , G.E., 2006.Metformin prevents endotoxin-induced liver injury after partial hepatectomy,J. Pharmacol. Exp. Ther. 316 1053 -1061
Bhat , A.,Sebastiani , G.,Bhat , M., 2015.Systematic review: Preventive and therapeutic applications of metformin in liver disease,World J. Hepatol. 7 1652 -1659
Cahova , M.,Palenickova , E.,Dankova , H.,Sticova , E.,Burian , M.,Drahota , Z.,Cervinkova , Z.,Kucera , O.,Gladkova , C.,Stopka , P.,Krizova , J.,Papackova , Z.,Oliyarnyk , O.,Kazdova , L., 2015.Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation,Am. J. Physiol Gastrointest. Liver Physiol 309 100 -111
Cao , J.,Meng , S.,Chang , E.,Beckwith-Fickas , K.,Xiong , L.,Cole , R.N.,Radovick , S.,Wondisford , F.E.,He , L., 2014.Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK),J. Biol. Chem 289 20435 -20446
Chu , C. K.,Chang , Y. T.,Lee , B. J.,Hu , S. Y.,Hu , W. H.,Yang , D. Y., 2003.Metformin-associated lactic acidosis and acute renal failure in a type 2 diabetic patient,J. Chin. Med 66 505 -508
Conde,Vrenken , T.E.,Buist-Homan , M.,Faber , K.N.,Moshage , H., 2015.Metformin protects primary rat hepatocytes against oxidative stressinduced apoptosis,Pharmacol. Res. Perspect. 3 e00125 -
Cone , C.J.,Bachyrycz , A.M.,Murata , G.H., 2010.Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease, 44 1655 -1659
Decker , S.O.,Wortmann , M.,Siegler , B.H.,Ulrich , A.,Hofer , S.,Brenner , T., 2015.Metformin-induced lactic acidosis : Severe symptoms with difficult diagnostics,Anaesthesist 64 292 -297
DeFronzo , R.,Fleming , G.A.,Chen , K.,Bicsak , T.A., 2016.Metformin-associated lactic acidosis: Current perspectives on causes and risk,Metabolism 65 20 -29
Fu , L.,Bruckbauer , A.,Li , F.,Cao , Q.,Cui , X.,Wu , R.,Shi , H.,Zemel , M.B.,Xue , B., 2015.Interaction between metformin and leucine in reducing hyperlipidemia and hepatic lipid accumulation in diet-induced obese mice,Metabolism 64 1426 -1434
Garofalo , C.,Iazzetta , N.,Camocardi , A.,Pacilio , M.,Iodice , C.,Minutolo , R.,N. L. & Conte,G., 2015.Anti-diabetics and chronic kidney disease, 32 -
Guo , Q.,Liu , Z.,Jiang , L.,Liu , M.,Ma , J.,Yang , C.,Han , L.,Nan , K.,Liang , X., 2016.Metformin inhibits growth of human nonsmall cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase,Mol. Med 13 2590 -2596
Hivert , M.F.,Christophi , C.A.,Franks , P.W.,Jablonski , K.A.,Ehrmann , D.A.,Kahn , S. E.,Horton , E.S.,Pollin , T.I.,Mather , K.J.,Perreault , L.,Barrett-Connor , E.,Knowler , W.C.,Florez , J.C., 2016.Lifestyle and Metformin Ameliorate Insulin Sensitivity Independently of the Genetic Burden of Established Insulin Resistance Variants in Diabetes Prevention Program Participants, 65 520 -526
Hostalek , U.,Gwilt , M.,Hildemann , S., 2015.Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention, 75 1071 -1094
Ismail , T. A.,Soliman , M. M.,Nassan , M. A., 2015.Molecular and immunohistochemical effects of metformin in a rat model of type 2 diabetes mellitus,Exp. Ther. Med 1921 -1930
Kutoh , E., 2005.Possible metformin-induced hepatotoxicity,Am. J. Geriatr. Pharmacother. 3 270 -273
Linden , M. A.,Lopez , K. T.,Fletcher , J. A.,Morris , E. M.,Meers , G. M.,Siddique , S.,Laughlin , M. H.,Sowers , J. R.,Thyfault , J. P.,Ibdah , J. A.,Rector , R. S., 2015.Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats,Appl. Physiol. Nutr 40 1038 -1047
Ling , S.,Tian , Y.,Zhang,Jia , K.,Feng , T.,Sun , D.,Gao , Z.,Xu , F.,Hou , Z.,Li , Y.,Wang , L., 2014.Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel7402/5 fluorouracil cells,Mol. Med 10 2891 -2897
Lovas , K.,Fadnes , D. J.,Dale , A., 2000.Metformin associated lactic acidosis-- case reports and literature review,Tidsskr. Nor Laegeforen 120 1539 -1541
Madiraju , A. K.,Erion , D. M.,Rahimi , Y.,Zhang , X. M.,Braddock , D. T.,Albright , R. A.,Prigaro , B. J.,Wood , J. L.,Bhanot , S.,Jurczak , M. J.,Camporez , J. P.,Lee , H. Y.,Cline , G. W.,Samuel , V. T.,Kibbey , R. G.,Shulman , G. I., 2014.Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase,Nature 510 542 -546
Malin , S. K.,Kashyap , S. R., 2014.Effects of metformin on weight loss: potential mechanisms,Curr. Opin. Endocrinol. Diabetes Obes. 21 323 -329
Meng , S.,Cao , J.,He , Q.,Xiong , L.,Chang , E.,Radovick , S.,Wondisford , F. E.,He , L., 2015.Metformin activates AMP-activated protein kinase by promoting formation of the alphabetagamma heterotrimeric complex,J.Biol. Chem 290 3793 -3802
Othman , E. M.,Oli , R. G.,Arias-Loza , P. A.,Kreissl , M. C.,Stopper , H., 2016.Metformin Protects Kidney Cells From Insulin-Mediated Genotoxicity In Vitro and in Male Zucker Diabetic Fatty Rats, 157 548 -559
Pilmore , H. L., 2010.Review: metformin: potential benefits and use in chronic kidney disease,Nephrol. 15 412 -418
Qu , H.,Yang , X., 2015.Metformin inhibits angiogenesis induced by interaction of hepatocellular carcinoma with hepatic stellate cells,Cell Biochem 71 931 -936
Rafieian-Kopaei , M.,Baradaran , A.,Merrikhi , A.,Nematbakhsh , M.,Madihi , Y.,Nasri , H., 2013.Efficacy of Co-administration of Garlic Extract and Metformin for Prevention of Gentamicin-Renal Toxicity in Wistar Rats: A Biochemical Study,Int. J. Prev. Med 4 258 -264
Reeker , W.,Schneider , G.,Felgenhauer , N.,Tempel , G.,Kochs , E., 2000.Metformininduced lactic acidosis,Dtsch. Med 125 249 -251
Saadi , T.,Waterman , M.,Yassin , H.,Baruch , Y., 2013.Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review,Int. J. Gen. Med 6 703 -706
Senesi , P.,Montesano , A.,Luzi , L.,Codella , R.,Benedini , S.,Terruzzi , I., 2016.Metformin Treatment Prevents Sedentariness Related Damages in Mice,J. Diabetes Res. 8274689 -
Sheta , A.,Elsakkar , M.,Hamza , M.,Solaiman , A., 2016.Effect of metformin and sitagliptin on doxorubicin-induced cardiotoxicity in adult male albino rats,Hum. Exp. Toxicol. 35 1227 -1239
Song , Y. M.,Lee , Y. H.,Kim , J. W.,Ham , D. S.,Kang , E. S.,Cha , B. S.,Lee , H. C.,Lee , B. W., 2015.Metformin alleviates hepatosteatosis by restoring SIRT1- mediated autophagy induction via an AMP-activated protein kinaseindependent pathway,Autophagy 11 46 -59
Sosnicki , S.,Kapral , M.,Weglarz , L., 2016.Molecular targets of metformin antitumor action,Pharmacol. Rep 68 918 -925
Subhasree , N.,Kamella , A.,Kaliappan , I.,Agrawal , A.,Dubey , G. P., 2015.Antidiabetic and antihyperlipidemic activities of a novel polyherbal formulation in high fat diet/streptozotocin induced diabetic rat model,Indian J. Pharmacol. 47 509 -513
Tan , S.,Vollmar , N.,Benson , S.,Sowa , J. P.,Bechmann , L. P.,Gerken , G.,Fuhrer , D.,Canbay , A., 2015.Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome,Int. J. Endocrinol. 254169 -
Tseng , C. H., 2016.Use of metformin and risk of kidney cancer in patients with type 2 diabetes,Eur. J. Cancer 52 19 -25
Viollet , B.,Guigas , B.,Sanz , G. N.,Leclerc , J.,Foretz , M.,Andreelli , F., 2012.Cellular and molecular mechanisms of metformin: an overview,Clin. Sci. (Lond) 122 253 -270
Wang , Z. S.,Liu , X. H.,Wang , M.,Jiang , G. J.,Qiu , T.,Chen , Z. Y.,Wang , L., 2015.Metformin attenuated the inflammation after renal ischemia/reperfusion and suppressed apoptosis of renal tubular epithelial cell in rats,Acta Cir 30 617 -623
Yang , X.,Sun , D.,Tian , Y.,Ling , S.,Wang , L., 2015.Metformin sensitizes hepatocellular carcinoma to arsenic trioxide-induced apoptosis by downregulating Bcl2 expression, 36 2957 -2964
Zheng , J.,Woo , S. L.,Hu , X.,Botchlett , R.,Chen , L.,Huo , Y.,Wu , C., 2015.Metformin and metabolic diseases: a focus on hepatic aspects, -
Zhong , Z. H.,Zhong , Z. Y.,Zhu , Z. T.,Li , C.,Zhang,Tong , M.,Jiang , H. M., 2015.Effect of metformin on the proliferation and apoptosis of the renal cancer cell line 786-O and the underlying mechanisms,J.Buon. 20 1244 -1249